Skip to content
    Compare notes on r/BodyHackGuideCompare notes with other researchers. Join r/BodyHackGuide

    Mazdutide vs 5-Amino-1MQ

    Side-by-side comparison of Mazdutide and 5-Amino-1MQ: mechanism, half-life, dose range, safety profile, and vendor pricing.

    Mazdutide: no price on file
    5-Amino-1MQ from $29.99

    Price snapshot

    Mazdutide

    Current low
    —
     
    7-day low
    —
    not enough history yet
    30-day low
    —
    not enough history yet
    30-day change
    —
    not enough history yet

    5-Amino-1MQ

    Current low
    $29.99
    current listings
    7-day low
    —
    not enough history yet
    30-day low
    —
    not enough history yet
    30-day change
    —
    not enough history yet

    Mazdutide

    Mazdutide (also known as IBI362, Lilly compound LY3305677) is a dual glucagon-like peptide-1 (GLP-1) and glucagon receptor agonist originally discovered by Eli Lilly and exclusively licensed to Innovent Biologics in 2019…

    No vendor price on file.

    Full Mazdutide profile

    5-Amino-1MQ

    5-Amino-1MQ (5-amino-1-methylquinolinium iodide) is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that transfers a methyl group from S-adenosyl-L-methionine (SAM) to nicotinamide to…

    Lowest listed price: $29.99 across 14 listings

    Full 5-Amino-1MQ profile

    Side-by-side comparison

    Attribute Mazdutide 5-Amino-1MQ
    Category Weight Loss Weight Loss
    Research Stage Approved (China, NMPA 2025); investigational in US/EU Preclinical
    Mechanism of Action Mazdutide engages two distinct receptor systems through a single peptide molecule, each contributing to metabolic effects. GLP-1 Receptor Agonism: Similar to semaglutide and liraglutide. GLP-1 binds to GLP-1 receptor (GLP1R), a Gαs-coupled G-protein-coupled… 5-Amino-1MQ works by inhibiting nicotinamide N-methyltransferase (NNMT), an enzyme that catalyzes the transfer of a methyl group from S-adenosyl-L-methionine (SAM) to the nitrogen of nicotinamide (vitamin B3 amide), producing 1-methylnicotinamide (1-MNA) and…
    Half-Life — ~6–12 hours (oral)
    Typical Dose Range Research doses — clinical trial protocols vary 50 mg - 150 mg daily (oral or injection)
    Dosing Frequency — Once daily oral
    Administration — Oral
    Side Effects Mazdutide's side-effect profile is dominated by gastrointestinal effects similar to GLP-1 agonists, with some dual-mechanism-specific considerations from the glucagon component. Most Common Side Effects: Gastrointestinal (dose-dependent): - Nausea: 40-55% at… The side effect profile of 5-amino-1MQ in humans is not documented because there are no human clinical trials. Rodent studies report generally good tolerability at doses producing metabolic and muscle benefits, without obvious signs of hepatotoxicity,…
    Molecular Weight 4563.14 g/mol 159.21 g/mol
    Common Vial Sizes — 50mg capsules, 100mg capsules

    Price History

    5 data points
    • OF
    • BM
    • Half Nattys
    • Ion Peptide
    • Disguised Alpha
    • RC
    • LB

    Mazdutide: potential benefits

    • Enhanced weight loss efficacy
    • Improved metabolic markers
    • Superior glucose control
    • Reduced cardiovascular risk factors

    5-Amino-1MQ: potential benefits

    • Enhanced fat metabolism and weight loss
    • Increased NAD+ levels in adipose tissue
    • Improved cellular energy production
    • Anti-aging properties via sirtuin activation

    Frequently asked

    What's the difference between Mazdutide and 5-Amino-1MQ?

    Mazdutide is a weight loss that mazdutide engages two distinct receptor systems through a single peptide molecule, each contributing to metabolic effects. glp-1 receptor agonism: similar to semaglutide and…. 5-Amino-1MQ is a weight loss that 5-amino-1mq works by inhibiting nicotinamide n-methyltransferase (nnmt), an enzyme that catalyzes the transfer of a methyl group from s-adenosyl-l-methionine (sam) to the nitrogen…. The two differ in mechanism, half-life (not reported vs ~6–12 hours (oral)), and typical dose range.

    Which has the longer half-life, Mazdutide or 5-Amino-1MQ?

    Mazdutide has a half-life of not reported. 5-Amino-1MQ has a half-life of ~6–12 hours (oral). Longer half-lives generally mean less frequent dosing but slower on/off kinetics.

    Can you stack Mazdutide and 5-Amino-1MQ?

    Stacking depends on mechanism overlap, safety profile, and goals. Mazdutide and 5-Amino-1MQ should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.

    See current vendor prices

    Listings from the vendors we track. Prices change often, so check the vendor before you buy.

    Mazdutide prices 5-Amino-1MQ prices Compare all compounds

    Before you buy Mazdutide or 5-Amino-1MQ

    Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.

    View Vendor Scorecard

    Related comparisons

    Mazdutide vs Tirzepatide5-Amino-1MQ vs Tirzepatide

    Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.